Literature DB >> 10737432

Course of viral load throughout HIV-1 infection.

C A Sabin1, H Devereux, A N Phillips, A Hill, G Janossy, C A Lee, C Loveday.   

Abstract

HIV-1 RNA levels are routinely monitored as part of patient management. However, little is known about the course of HIV-1 RNA levels over the entire period of infection. The aim of this study was to investigate the course of HIV-1 RNA levels in a cohort of men with hemophilia who were observed for up to 17 years after HIV-1 seroconversion, and to assess the risk of HIV disease progression at any HIV-1 RNA level. Viral loads were measured on annual stored serum samples in 107 men with hemophilia A using the Roche Amplicor Monitor assay with non-B primers. On average, HIV-1 RNA levels increased significantly by 0.11 log10 per year over the course of HIV infection. This rate of increase was significantly faster in those who developed AIDS or died over the subsequent 12 to 17 year period, and in those who were older at HIV- 1 seroconversion. The risk of developing AIDS and death remained low when the HIV-1 RNA level was below 4 log10 copies/ml, but increased rapidly thereafter, supporting current guidelines for the initiation of antiretroviral therapy after the viral load has exceeded this level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737432     DOI: 10.1097/00126334-200002010-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  16 in total

1.  The role of mutation accumulation in HIV progression.

Authors:  Alison P Galvani
Journal:  Proc Biol Sci       Date:  2005-09-07       Impact factor: 5.349

2.  Precise determination of time to reach viral load set point after acute HIV-1 infection.

Authors:  Xiaojie Huang; Hui Chen; Wei Li; Haiying Li; Xia Jin; Alan S Perelson; Zoe Fox; Tong Zhang; Xiaoning Xu; Hao Wu
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

Review 3.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load.

Authors:  Lele Zhao; Chris Wymant; François Blanquart; Tanya Golubchik; Astrid Gall; Margreet Bakker; Daniela Bezemer; Matthew Hall; Swee Hoe Ong; Jan Albert; Norbert Bannert; Jacques Fellay; M Kate Grabowski; Barbara Gunsenheimer-Bartmeyer; Huldrych F Günthard; Pia Kivelä; Roger D Kouyos; Oliver Laeyendecker; Laurence Meyer; Kholoud Porter; Ard van Sighem; Marc van der Valk; Ben Berkhout; Paul Kellam; Marion Cornelissen; Peter Reiss; Christophe Fraser; Luca Ferretti
Journal:  Virus Evol       Date:  2022-03-16

5.  Clinical, immunological and virological evolution in patients with CD4 T-cell count above 500/mm3: is there a benefit to treat with highly active antiretroviral therapy (HAART)?

Authors:  Lionel Piroth; Christine Binquet; Marielle Buisson; Evelyne Kohli; Michel Duong; Michèle Grappin; Michal Abrahamowicz; Catherine Quantin; Henri Portier; Pascal Chavanet
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

Authors:  Sara Lodi; Marguerite Guiguet; Dominique Costagliola; Martin Fisher; Andrea de Luca; Kholoud Porter
Journal:  J Natl Cancer Inst       Date:  2010-05-04       Impact factor: 13.506

Review 7.  Modeling antiretroviral drug responses for HIV-1 infected patients using differential equation models.

Authors:  Yanni Xiao; Hongyu Miao; Sanyi Tang; Hulin Wu
Journal:  Adv Drug Deliv Rev       Date:  2013-04-17       Impact factor: 15.470

8.  HIV-1 Disease Progression and Survival in an Adult Population in Zimbabwe: Is There an Effect of the Mannose Binding Lectin Deficiency?

Authors:  Rutendo B L Zinyama-Gutsire; Charles Chasela; Per Kallestrup; Simbarashe Rusakaniko; Michael Christiansen; Bernard Ngara; Exnevia Gomo; Henrik Ullum; Christian Erikstrup; Hans O Madsen; Babill Stray-Pedersen; Peter Garred; Takafira Mduluza
Journal:  OMICS       Date:  2015-09

Review 9.  Cell-associated HIV RNA: a dynamic biomarker of viral persistence.

Authors:  Alexander O Pasternak; Vladimir V Lukashov; Ben Berkhout
Journal:  Retrovirology       Date:  2013-04-15       Impact factor: 4.602

10.  The HIV RNA setpoint theory revisited.

Authors:  Ronald B Geskus; Maria Prins; Jean-Baptiste Hubert; Frank Miedema; Ben Berkhout; Christine Rouzioux; Jean-Francois Delfraissy; Laurence Meyer
Journal:  Retrovirology       Date:  2007-09-21       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.